EDGE
Get a demo
Log In

Limbix (acquired by Big Health)

Mental Health Tech
Product stageSegments
Seed
?
Digital Therapeutics
?

Limbix is a digital therapeutic developer focused on treating adolescent mental health conditions. The company is running clinical trials for its flagship product, Limbix Spark, as of April 2022. The product comprises a multi-week, self-guided, app-based cognitive behavioral therapy program where patients complete activities that provide a feeling of gratification and mastery to reduce symptoms of depression. The company sought feedback from focus groups of teenagers regarding the interface design, including the color scheme and avatar, when developing Limbix Spark. 

Founded in 2016, California-based Limbix plans to seek US Food and Drug Administration approval in 2022 and position itself as the first prescription-based digital therapeutic treatment for adolescent depression. In February 2021, the company received a grant of USD 3.6 million from the National Institute of Mental Health to study the efficiency and safety of Limbix Spark in collaboration with the Duke Clinical Research Institute over a three-year period.

Funding and financials

The company concluded a USD 15 million Series A2 funding round led by GSR Ventures that brought total funds raised to USD 31 million. The latest funding follows the company’s Series A round of USD 9 million in May 2020. The funds will be used to commercialize its SparkRx prescription digital therapeutic (PDT) which was launched in October 2021. Additionally, it plans to double its staff cadre by Q2 2022 and expedite the development of new PDTs focusing on additional treatments for mental health needs in pediatrics. The funding round also follows its recent announcement that a clinical trial had demonstrated a statistically significant reduction in depression symptoms in users who completed the program as recommended.

In July 2023, the company was acquired by Big Health for an undisclosed amount.

Mental Health Tech

Mental Health Tech

Key stats
Featured companies
198
Total funding (USD)
11.7 Bn
Total addressable market (USD)
94.3 Bn
Key competitors
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

Recent Updates

M&A
Jul 14, 2023
Big Health acquires Limbix for undisclosed amount
Mental Health Tech
Funding
Dec 7, 2021
Limbix raises USD 15 million in Series A2 funding
Mental Health Tech

Company Brief


HQ location:
839 Emerson Street Palo Alto CA USA
Founded year:
2016
Employees:
11-50
Total Funding:
USD 31.0 million
Last Funding
USD 15.0 million, Dec 2021

Funding


Investors


No investor data is available

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.